Xuexing He

发表

A pharmacokinetic and safety study of single dose intravenous combretastatin A4 phosphate in Chinese patients with refractory solid tumours.

Tongyu Lin, Likun Chen, Zhiming Li, 2011, British journal of clinical pharmacology.

Comparison of KRAS/BRAF mutations between primary tumors and serum in colorectal cancer: Biological and clinical implications.

Ying Huang, Z. Pan, Shaodan Zhang, 2013, Oncology letters.

Schedule-dependent inhibition of T-cell lymphoma cells by cotreatment with the mTOR inhibitor everolimus and anticancer drugs

Yan Huang, Zhiming Li, Ying Tian, 2012, Investigational New Drugs.